These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 14694668)
21. [A vaccination would prevent invasive pneumococcal infections in adults]. Herva E; Sankilampi U; Leinonen M Duodecim; 1997; 113(8):689-91. PubMed ID: 11466867 [No Abstract] [Full Text] [Related]
22. Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey. Smith PJ; Nuorti JP; Singleton JA; Zhao Z; Wolter KM Pediatrics; 2007 Nov; 120(5):e1165-73. PubMed ID: 17974712 [TBL] [Abstract][Full Text] [Related]
23. Invasive pneumococcal disease in the Kimberley, 1995-2001. Mak DB Aust J Rural Health; 2004 Dec; 12(6):237-40. PubMed ID: 15615574 [TBL] [Abstract][Full Text] [Related]
24. Pneumococcal vaccination in splenectomised cancer patients. Omlin AG; Mühlemann K; Fey MF; Pabst T Eur J Cancer; 2005 Aug; 41(12):1731-4. PubMed ID: 16026979 [TBL] [Abstract][Full Text] [Related]
25. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974 [TBL] [Abstract][Full Text] [Related]
26. Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians. Metersky ML; Mennone JZ; Fine JM Conn Med; 1998 Nov; 62(11):649-54. PubMed ID: 9874889 [TBL] [Abstract][Full Text] [Related]
27. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006. Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825 [TBL] [Abstract][Full Text] [Related]
28. [Antipneumococcal vaccine: up date and prospective]. Caramia G; Pastorelli G Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607 [TBL] [Abstract][Full Text] [Related]
29. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Musher DM; Rueda-Jaimes AM; Graviss EA; Rodriguez-Barradas MC Clin Infect Dis; 2006 Oct; 43(8):1004-8. PubMed ID: 16983612 [TBL] [Abstract][Full Text] [Related]
30. [Fulminant pneumococcal sepsis in two splenectomized patients]. de Vries PA; Oei-Reyners AK; Möller AV; Timens W; Tulleken JE; van der Werf TS Ned Tijdschr Geneeskd; 2003 Mar; 147(10):450-4. PubMed ID: 12666517 [TBL] [Abstract][Full Text] [Related]
31. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study. Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313 [TBL] [Abstract][Full Text] [Related]
32. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369 [TBL] [Abstract][Full Text] [Related]
33. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong. Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837 [TBL] [Abstract][Full Text] [Related]
34. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897 [TBL] [Abstract][Full Text] [Related]
35. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Metlay JP; Fishman NO; Joffe M; Edelstein PH Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826 [TBL] [Abstract][Full Text] [Related]
36. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine. Silfverdal SA; Berg S; Hemlin C; Jokinen I Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905 [TBL] [Abstract][Full Text] [Related]
38. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants. Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934 [TBL] [Abstract][Full Text] [Related]
39. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981 [TBL] [Abstract][Full Text] [Related]
40. Early predictors of mortality in pneumococcal bacteraemia. Balakrishnan I; Crook P; Morris R; Gillespie SH J Infect; 2000 May; 40(3):256-61. PubMed ID: 10908020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]